Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study

被引:38
作者
Parrella, Adriana [1 ,2 ]
Braunack-Mayer, Annette [3 ]
Gold, Michael [1 ]
Marshall, Helen [1 ]
Baghurst, Peter [1 ]
机构
[1] Univ Adelaide, Sch Paediat & Reprod Hlth, Discipline Paediat, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Populat Hlth, Discipline Publ Hlth, Adelaide, SA, Australia
[3] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia
基金
英国医学研究理事会;
关键词
Adverse event following immunisation (AEFI); Surveillance; Healthcare provider; Reporting; Qualitative; ASSESSING VACCINE SAFETY; DRUG-REACTIONS; SURVEILLANCE; BARRIERS; SYSTEM; ATTITUDES; CHILDREN; ROUTINE; MODEL;
D O I
10.1186/1472-6963-13-313
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Healthcare provider spontaneous reporting of suspected adverse events following immunisation (AEFI) is central to monitoring post-licensure vaccine safety, but little is known about how healthcare professionals recognise and report to surveillance systems. The aim of this study was explore the knowledge, experience and attitudes of medical and nursing professionals towards detecting and reporting AEFI. Methods: We conducted a qualitative study, using semi-structured, face to face interviews with 13 Paediatric Emergency Department consultants from a tertiary paediatric hospital, 10 General Practitioners, 2 local council immunisation and 4 General Practice nurses, recruited using purposive sampling in Adelaide, South Australia, between December 2010 and September 2011. We identified emergent themes related to previous experience of an AEFI in practice, awareness and experience of AEFI reporting, factors that would facilitate or impede reporting and previous training in vaccine safety. Thematic analysis was used to analyse the data. Results: AEFI reporting was infrequent across all groups, despite most participants having reviewed an AEFI. We found confusion about how to report an AEFI and variability, according to the provider group, as to the type of events that would constitute a reportable AEFI. Participants' interpretation of a "serious" or "unexpected" AEFI varied across the three groups. Common barriers to reporting included time constraints and unsatisfactory reporting processes. Nurses were more likely to have received formal training in vaccine safety and reporting than medical practitioners. Conclusions: This study provides an overview of experience and beliefs of three healthcare professional groups in relation to identifying and reporting AEFI. The qualitative assessment reveals differences in experience and awareness of AEFI reporting across the three professional groups. Most participants appreciated the importance of their role in AEFI surveillance and monitoring the ongoing safety of vaccines. Future initiatives to improve education, such as increased training to health care providers, particularly, medical professionals, are required and should be included in both undergraduate curricula and ongoing, professional development.
引用
收藏
页数:12
相关论文
共 40 条
[21]   Physicians' attitudes and adverse drug reaction reporting -: A case-control study in Portugal [J].
Herdeiro, MT ;
Figueiras, A ;
Polónia, J ;
Gestal-Otero, JJ .
DRUG SAFETY, 2005, 28 (09) :825-833
[22]   Reporting of adverse events following immunization in Australia [J].
Isaacs, D ;
Lawrence, G ;
Boyd, I ;
Ronaldson, K ;
McEwen, J .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2005, 41 (04) :163-166
[23]   The role of the vaccine adverse event reporting system (VAERS) in monitoring vaccine safety [J].
Iskander, JK ;
Miller, ER ;
Chen, RT .
PEDIATRIC ANNALS, 2004, 33 (09) :599-606
[24]   Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study [J].
Jacobson, RM ;
Adegbenro, A ;
Pankratz, VS ;
Poland, GA .
VACCINE, 2001, 19 (17-19) :2428-2433
[25]  
Kim JH, 2012, JPN J INFECT DIS, V65, P99
[26]  
Lawrence GL, 2009, COMMUN DIS INTELL, V33, P27
[27]   Barriers to incident reporting in a healthcare system [J].
Lawton, R ;
Parker, D .
QUALITY & SAFETY IN HEALTH CARE, 2002, 11 (01) :15-18
[28]   Improving global monitoring of vaccine safety - A survey of national centres participating in the WHO programme for International Drug Monitoring [J].
Letourneau, Megan ;
Wells, George ;
Walop, Wikke ;
Duclos, Philippe .
DRUG SAFETY, 2008, 31 (05) :389-398
[29]   Improving global monitoring of vaccine safety: A quantitative analysis of adverse event reports in the WHO Adverse Reactions Database [J].
Letourneau, Megan ;
Wells, George ;
Walop, Wikke ;
Duclos, Philippe .
VACCINE, 2008, 26 (09) :1185-1194
[30]   Monitoring and assessing vaccine safety: a European perspective [J].
Lopalco, Pier Luigi ;
Johansen, Kari ;
Ciancio, Bruno ;
Gomes, Helena De Carvalho ;
Kramarz, Piotr ;
Giesecke, Johan .
EXPERT REVIEW OF VACCINES, 2010, 9 (04) :371-380